Pulsus Group Invests Rs 300 Crore in Telangana AI-driven Pharma Hub
Pulsus Group is set to establish an AI-driven pharma healthcare IT hub in Ameenpur, located in Telangana's Sangareddy district. The project, with an estimated investment of Rs 300 crore, is expected to generate approximately 50,000 jobs.
During the inaugural day of the 73rd Indian Pharmaceutical Congress, Pulsus Group CEO and Managing Director, Dr. Srinubabu Gedela, announced the project. He stated that the initiative will revolutionize the healthcare and IT sectors by creating an estimated 10,000 direct jobs and approximately 40,000 indirect jobs through supporting industries and services.
Dr. Gedela mentioned that the project, situated within the IT/ITeS zone in Ameenpur, will leverage AI innovations to enhance various aspects of the pharmaceutical industry, from research and development to healthcare delivery. This initiative is expected to create a significant number of jobs for local residents.
“By integrating the most advanced artificial intelligence, we aim to streamline processes, enhance precision in drug development, and improve patient outcomes. This positions Telangana at the forefront of healthcare innovation in India", Gedela said.
Speaking at the conclave, Telangana Industries and IT Minister D. Sridhar Babu stated that the pharmaceutical industry's adoption of AI and other advanced technologies should contribute to making medications and treatments more affordable for patients.
To enhance Telangana and Hyderabad's potential as a global pharmaceutical hub, Telangana Chief Minister A. Revanth Reddy has decided to implement a cluster-based and decentralized development strategy. This approach will involve establishing 9-10 pharmaceutical zones across the state to create a self-sustaining ecosystem and generate employment in rural areas, he announced. The three-day conclave is attended by over 12,000 delegates, including pharmacy students.
